-
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy
van Buchem-Post, N. F., Ouwerkerk, W., Stalman, E. W., van Dam, K. P. J., Wieske, L., Bekkenk, M. W., Wolkerstorfer, A., Spuls, P., Musters, A. H., Bosma, A. L., Hijnen, D.-J., Eftimov, F., Luiten, R. M. & T2B! immunity against SARS-CoV-2 study group, Apr 2025, In: Journal of dermatology. 52, 4, p. 624-633 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis
Broens, B., Nossent, E. J., Meijboom, L. J., Zwezerijnen, G. J. C., Spierings, J., de Vries-Bouwstra, J. K., van Laar, J. M., van der Laken, C. J. & Voskuyl, A. E., 1 Dec 2024, In: Arthritis Research and Therapy. 26, 1, 219.Research output: Contribution to journal › Article* › Academic › peer-review
-
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
the T2B! immunity against SARS-CoV-2 study group, Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S. & T2B! immunity against SARS-CoV-2 study group, Sept 2024, In: Journal of allergy and clinical immunology. 154, 3, p. 754-766.e7Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
